*Please note that this translation is to be used solely as reference.
In case of any discrepancy between this translation and the Japanese original, the latter shall prevail.
First Half of FY 2023
Financial Results Briefing
Friday, November 25, 2022
Linical Co.,Ltd.
TSE Prime 2183
Contents
1. Company Overview | P. 2 - 4 |
2. Financial Results for the Six Months | |
Ended September 30, 2022 | P. 5 - 13 |
3. Growth Strategy | P. 14 - 39 |
1． Company Overview
Global CRO from Japan
- Locations of Overseas Bases
Sweden
Portugal
Germany
Spain Czech Republic
Poland France
Hungary Romania
UK Netherlands
Italy
October 2022
Establishment of an
Italian subsidiary
Beijing | Canada | |||
Korea | ||||
Tokyo | San Diego | New York | ||
Shanghai | Osaka | |||
India | (Linical Headquarters) | Florida | ||
Taiwan | Mexico | |||
Philippines | ||||
Singapore | Brazil | |||
Indonesia | ||||
Australia | Chile | Argentina | ||
Red: Headquarters Orange: Branch Pink: Subsidiary Blue: Subsidiary Green: CRA Employment ash: Under consideration as base
Linical aims to be a global CRO originating in Japan and undertakes to new drug development as a drug development professional
We have advanced overseas positively since the founding of the company and currently operate in 18 countries and regions
3
The Three Businesses of Linical
- We specialize in clinical development and cover the entire process from the innovative drug development stage through to the new drug development and approval stages.
Innovative drug
development
process
Basic research | Application to | Clinical trials | Post-marketing | |
(2 to 3 years) to | New drug | surveillance and | ||
start a new | phases I to III | |||
non-clinical trials | application | clinical trials | ||
drug trial | (3 to 7 years) | |||
(3 to 5 years) | (4 to 10 years) | |||
The three
businesses of
Linical
CRO business | Contract Medical Affairs | |
From 2005 | From 2011 | |
Innovative Drug | ● Market analysis ● Handling of pharmaceutical affairs |
Development Business● Development strategy planning ● Partnering support
From 2016
- We have developed three businesses centered on CRO business.
• Contract Medical Affairs business: | We support post-marketing clinical research and marketing activities |
- Innovative Drug Development Business :We provide consulting services that give total support for a wide range of pharmaceutical development activities including market analysis, the formulation of pharmaceutical affairs and development strategies, the selection of marketing partners, and the conclusion of contracts.
4
This is an excerpt of the original content. To continue reading it, access the original document here.